1. Case characteristics, resource use, and outcomes of 10 021 patients with COVID-19 admitted to 920 German hospitals: an observational study. Issue 9 (September 2020) Authors: Karagiannidis, Christian; Mostert, Carina; Hentschker, Corinna; Voshaar, Thomas; Malzahn, Jürgen; Schillinger, Gerhard; Klauber, Jürgen; Janssens, Uwe; Marx, Gernot; Weber-Carstens, Steffen; Kluge, Stefan; Pfeifer, Michael; Grabenhenrich, Linus; Welte, Tobias; Busse, Reinhard Journal: Lancet Issue: Volume 8:Issue 9(2020) Page Start: 853 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Conservative management of COVID-19 associated hypoxaemia. Issue 2 (21st June 2021) Authors: Voshaar, Thomas; Stais, Patrick; Köhler, Dieter; Dellweg, Dominic Journal: ERJ open research Issue: Volume 7:Issue 2(2021) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Conservative management of COVID-19 associated hypoxaemia. Issue 2 (6th April 2021) Authors: Voshaar, Thomas; Stais, Patrick; Köhler, Dieter; Dellweg, Dominic Journal: ERJ open research Issue: Volume 7:Issue 2(2021) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Delivery characteristics of a low-resistance dry-powder inhaler used to deliver the long-acting muscarinic antagonist glycopyrronium*. (20th February 2013) Authors: Colthorpe, Paul; Voshaar, Thomas; Kieckbusch, Thomas; Cuoghi, Erika; Jauernig, Juergen Journal: Journal of drug assessment Issue: Volume 2(2013) Page Start: 11 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Delivery characteristics of a low-resistance dry-powder inhaler used to deliver the long-acting muscarinic antagonist glycopyrronium. (23rd April 2013) Authors: Colthorpe, Paul; Voshaar, Thomas; Kieckbusch, Thomas; Cuoghi, Erika; Jauernig, Juergen Journal: Journal of drug assessment Issue: Volume 2(2013) Page Start: 11 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Lung Deposition Using the Respimat® Soft Mist™ Inhaler Mono and Fixed-Dose Combination Therapies: An In Vitro/In Silico Analysis. (23rd November 2020) Authors: Ciciliani, Anna-Maria; Denny, Mark; Langguth, Peter; Voshaar, Thomas; Wachtel, Herbert Journal: COPD Issue: Volume 18:Number 1(2021) Page Start: 91 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗